Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer

被引：16
作者：
Fouchard, Maxime [1 ]
Jantzem, Helene [2 ]
Quere, Gilles [1 ]
Descourt, Renaud [1 ]
Robinet, Gilles [1 ]
Poureau, Pierre-Guillaume [1 ]
机构：
[1] Univ Hosp, Dept Oncol, F-29609 Brest, France
[2] Univ Hosp, Dept Pharmacovigilance, Brest, France
来源：
EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷
关键词：
Immunotherapy; Cholangitis; Immune adverse event; NIVOLUMAB;
D O I：
10.1016/j.ejca.2019.04.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：107 / 110
页数：4
相关论文
共 5 条
  • [1] EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
    Beuers, Ulrich
    Boberg, Kirsten M.
    Chapman, Roger W.
    Chazouilleres, Olivier
    Invernizzi, Pietro
    Jones, David E. J.
    Lammert, Frank
    Pares, Albert
    Trauner, Michael
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 237 - 267
  • [2] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
    Brahmer, Julie R.
    Lacchetti, Christina
    Schneider, Bryan J.
    Atkins, Michael B.
    Brassil, Kelly J.
    Caterino, Jeffrey M.
    Chau, Ian
    Ernstoff, Marc S.
    Gardner, Jennifer M.
    Ginex, Pamela
    Hallmeyer, Sigrun
    Chakrabarty, Jennifer Holter
    Leighl, Natasha B.
    Mammen, Jennifer S.
    McDermott, David F.
    Naing, Aung
    Nastoupil, Loretta J.
    Phillips, Tanyanika
    Porter, Laura D.
    Puzanov, Igor
    Reichner, Cristina A.
    Santomasso, Bianca D.
    Seigel, Carole
    Spira, Alexander
    Suarez-Almazor, Maria E.
    Wang, Yinghong
    Weber, Jeffrey S.
    Wolchok, Jedd D.
    Thompson, John A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) : 1714 - +
  • [3] Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury
    Gelsomino, F.
    Vitale, G.
    D'Errico, A.
    Bertuzzi, C.
    Andreone, P.
    Ardizzoni, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (03) : 671 - 672
  • [4] A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event
    Gelsomino, Francesco
    Vitale, Giovanni
    Ardizzoni, Andrea
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 144 - 146
  • [5] Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report
    Kashima, Jumpei
    Okuma, Yusuke
    Shimizuguchi, Ryoko
    Chiba, Kazuro
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (01) : 61 - 65
1